Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2016 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Edelweiss Large & Mid Cap Fund |
|---|---|
| 28 Nov 2016 | ₹100.00 |
| 20 Sep 2017 | ₹118.71 |
| 13 Jul 2018 | ₹123.28 |
| 05 May 2019 | ₹113.57 |
| 25 Feb 2020 | ₹124.52 |
| 17 Dec 2020 | ₹116.17 |
| 09 Oct 2021 | ₹149.91 |
| 01 Aug 2022 | ₹139.44 |
| 24 May 2023 | ₹146.69 |
| 15 Mar 2024 | ₹187.47 |
| 05 Jan 2025 | ₹234.22 |
| 28 Oct 2025 | ₹236.59 |
| 20 Aug 2026 | ₹245.28 |
| Metric | Edelweiss · Regular · IDCW NAV ₹35.05 Very High risk ★★★★★ | Category median Large & Mid Cap Fund · 35 funds |
|---|---|---|
| +5.96% | +3.02% | |
| +15.16% | +9.47% | |
| +11.28% | +9.57% | |
| — | +8.51% | |
| +9.67% | +8.27% | |
| +12.90% | — | |
| +10.18% | +10.05% | |
| +10.32% | +9.17% | |
| — | +6.32% | |
| Risk | ||
| 15.11% | 15.59% | |
| 0.57 | 0.10 | |
| 0.78 | 0.12 | |
| -42.76% | -42.76% | |
| Nifty Midcap 150 | — | |
| -0.69% | -5.64% | |
| 0.83 | 0.85 | |
| 82.7% | 79.3% | |
| 80.1% | 97.2% | |
| 2.02% | 2.30% | |
| ₹63.87Cr | ₹4,527Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 36% | 40% | |
| Trideep Bhattacharya · 4.7y | — | |
| 28 Nov 2016 | — | |
| 87 | — | |
| 23.4% | — | |
| 0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.